Alexander's: A NYC Retail REIT To Keep Benched, As Portfolio Growth Remains Quiet
Alexander's (ALX) Price Target Increased by 11.58% to 216.24
Alexander's Q2 FFO $3.02 Beats $2.99 Estimate, Sales $54.711M Beat $54.000M Estimate
Piper Sandler Maintains Underweight on Alexander's, Raises Price Target to $212
Alexander's Q1 FFO $2.60 Misses $3.08 Estimate, Sales $53.412M Miss $53.800M Estimate
Alexander's Agrees To Sell Its Rego Park I Property To Northwell Health For Gross Purchase Price Of $235.5M
Why Alexander's (ALX) Is Down 6.7% After Weaker 2025 Results And Steady Dividend Declaration
Alexander's Q4 Earnings Call Highlights
Alexander's Inc (ALX) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ...
Alexander's: Q4 Earnings Snapshot
Alexander’s Announces Fourth Quarter Financial Results
Alexander's shares are trading lower after the company reported worse-than-expected Q4 financial results.
Earnings Breakdown: Alexander's Q4
Alexander's Q4 FFO $2.43 Misses $3.02 Estimate, Sales $53.255M Miss $53.400M Estimate
Is Alexander's (ALX) Stock Outpacing Its Finance Peers This Year?
Uncovering Potential: Alexander's's Earnings Preview
Alexander’s Declares Quarterly $4.50 Dividend on Common Shares
Assessing Alexander’s (ALX) Valuation As Shares Deliver Strong Recent Returns
Alexander’s Completes Restructuring of Retail Loan at 731 Lexington Avenue
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.